Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Neonates With Elevated A-a DO2
NCT00041548Phase 2Terminated
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- May 2002
- Primary completion
- Jun 2005
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in hypoxemia, sponsored by Mallinckrodt Pharmaceuticals. Started May 2002; status: terminated.
02
Drugs
nitric oxide
03
Conditions
hypoxemia
Beyond the preview
Go deeper on NCT00041548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041548.